First-in-human, single ascending dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of piromelatine [Neu-P11] in healthy male volunteers

Trial Profile

First-in-human, single ascending dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of piromelatine [Neu-P11] in healthy male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Feb 2013

At a glance

  • Drugs Piromelatine (Primary)
  • Indications Insomnia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 21 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top